Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Public ClinicalTrials.gov record NCT06644573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT06644573
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Nyree Penn
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
- Alzheimer Disease or Associated Disorder
- Anesthesia
- Anxiety
- Athletes
- Cancer Pain
- Chronic Insomnia
- Circadian Dysregulation
- Circadian Rhythm
- Depression
- Idiopathic Hypersomnia
- Insomnia
- Insomnia Comorbid to Psychiatric Disorder
- Insomnia Disorders
- Insomnia Due to Anxiety and Fear
- Insomnia Due to Other Mental Disorder
- Insomnia Related to Another Mental Condition
- Insomnia Related to Specified Disorder
- Menopause Related Conditions
- Mental Health
- Military Activity
- Military Combat Stress Reaction
- PTSD
- PTSD - Post Traumatic Stress Disorder
- Pain
- Parkinsons
- Post Trauma Nightmares
- Post-Traumatic
- Post-Traumatic Stress Disorder Complex
- REM Behavior Disorder
- REM Sleep Behavior Disorder
- REM Sleep Measurement
- Shift Work Sleep Disorder
- Sleep
- Sleep Deprivation
- Sleep Disorders, Circadian Rhythm
- Sleep Quality
- Veterans
Interventions
- Anesthesia-Induced Sleep Therapy Procedure
- Continuous EEG Monitoring Device
- Diprivan (propofol), Astra-Zeneca Drug
- PROSOMNIA Sleep Therapy™ (PSTx) Procedure
Procedure · Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
- Last update posted
- May 27, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| PROSOMNIA Sleep Health and Wellness | Aventura | Florida | 33180 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06644573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06644573 live on ClinicalTrials.gov.